Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | REGN | ARGX | ||
| Company | Celgene Corp | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 108.01 | 760.00 | 785.28 | ||
| High | 108.59 | 761.96 | 787.08 | ||
| Low | 107.27 | 736.71 | 778.20 | ||
| Latest | 108.24 | 751.57 | 780.25 | ||
| Change | +0.11 | -14.45 | -7.70 | ||
| % Change | +0.10% | -1.89% | -0.98% | ||
| Volume | 191,230,496 | 809,500 | 339,100 | ||
| 20-Day Average Volume | 16,188,930 | 660,930 | 309,725 | ||
| Previous Close | 108.13 | 766.02 | 787.95 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 756.39 | 783.58 | ||
| 20-Day Raw Stochastic | 63.25% | 37.06% | 55.38% | ||
| 20-Day Relative Strength | 64.69 | 48.47 | 50.57 | ||
| Weighted Alpha | +46.30 | +27.91 | +22.07 | ||
| Today's Opinion | 100% Buy | 16% Buy | 8% Sell | ||
| Previous Opinion | 100% Buy | 64% Buy | 8% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | +0.13% since 04/17/26 | -8.10% since 04/17/26 | ||
| Low | 107.27 on 11/20/19 | 734.12 on 04/21/26 | 778.20 on 04/24/26 | ||
| High | 110.53 on 11/14/19 | 767.21 on 04/23/26 | 847.20 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | +1.33% since 03/24/26 | +15.17% since 03/24/26 | ||
| Low | 102.40 on 10/21/19 | 734.12 on 04/21/26 | 685.68 on 03/25/26 | ||
| High | 110.70 on 11/13/19 | 781.21 on 04/01/26 | 852.28 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | -0.26% since 01/23/26 | -4.23% since 01/23/26 | ||
| Low | 93.41 on 08/23/19 | 727.88 on 03/19/26 | 661.85 on 03/20/26 | ||
| High | 110.70 on 11/13/19 | 815.00 on 02/17/26 | 881.89 on 01/27/26 | ||
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | +30.04% since 10/24/25 | -4.54% since 10/24/25 | ||
| Low | 89.08 on 07/23/19 | 575.93 on 10/27/25 | 661.85 on 03/20/26 | ||
| High | 110.70 on 11/13/19 | 821.11 on 01/09/26 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 79,455,984 | 48,522,180 | ||
| Shares Outstanding, K | 711,714 | 105,720 | 62,188 | ||
| Annual Sales | 15,281,000,000 | 14,342,900,000 | 4,248,050,000 | ||
| Annual Net Income | 4,046,000,000 | 4,504,900,000 | 1,292,040,000 | ||
| Last Quarter Sales | 4,520,000,000 | 3,884,300,000 | 1,322,160,000 | ||
| Last Quarter Net Income | 1,691,000,000 | 844,600,000 | 532,950,000 | ||
| 60-Month Beta | 1.41 | 0.40 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | 11.44 on 01/30/26 | 8.02 on 02/26/26 | ||
| Latest Earnings Date | 01/30/20 | 04/29/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | 0.940 on 02/20/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 21.23 | 40.37 | ||